Aghi M - Search Results

1

Chiocca EA, Aghi M, Fulci G. Chiocca EA, et al. Among authors: aghi m. Cancer J. 2003 May-Jun;9(3):167-79. doi: 10.1097/00130404-200305000-00005. Cancer J. 2003. PMID: 12952302 Review.

2

Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy.

Kramm CM, Chase M, Herrlinger U, Jacobs A, Pechan PA, Rainov NG, Sena-Esteves M, Aghi M, Barnett FH, Chiocca EA, Breakefield XO. Kramm CM, et al. Among authors: aghi m. Hum Gene Ther. 1997 Nov 20;8(17):2057-68. doi: 10.1089/hum.1997.8.17-2057. Hum Gene Ther. 1997. PMID: 9414254

3

Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies.

Aghi M, Kramm CM, Chou TC, Breakefield XO, Chiocca EA. Aghi M, et al. J Natl Cancer Inst. 1998 Mar 4;90(5):370-80. doi: 10.1093/jnci/90.5.370. J Natl Cancer Inst. 1998. PMID: 9498487

4

Multimodal cancer treatment mediated by a replicating oncolytic virus that delivers the oxazaphosphorine/rat cytochrome P450 2B1 and ganciclovir/herpes simplex virus thymidine kinase gene therapies.

Aghi M, Chou TC, Suling K, Breakefield XO, Chiocca EA. Aghi M, et al. Cancer Res. 1999 Aug 15;59(16):3861-5. Cancer Res. 1999. PMID: 10463570

5

Prodrug activation enzymes in cancer gene therapy.

Aghi M, Hochberg F, Breakefield XO. Aghi M, et al. J Gene Med. 2000 May-Jun;2(3):148-64. doi: 10.1002/(SICI)1521-2254(200005/06)2:3<148::AID-JGM105>3.0.CO;2-Q. J Gene Med. 2000. PMID: 10894261 Review.

6

Genetically engineered herpes simplex viral vectors in the treatment of brain tumors: a review.

Aghi M, Chiocca EA. Aghi M, et al. Cancer Invest. 2003 Apr;21(2):278-92. doi: 10.1081/cnv-120016423. Cancer Invest. 2003. PMID: 12743992 Review. No abstract available.

7

Contribution of bone marrow-derived cells to blood vessels in ischemic tissues and tumors.

Aghi M, Chiocca EA. Aghi M, et al. Mol Ther. 2005 Dec;12(6):994-1005. doi: 10.1016/j.ymthe.2005.07.693. Epub 2005 Aug 30. Mol Ther. 2005. PMID: 16137927 Free article. Review.

8

Viral vectors as therapeutic agents for glioblastoma.

Aghi M, Rabkin S. Aghi M, et al. Curr Opin Mol Ther. 2005 Oct;7(5):419-30. Curr Opin Mol Ther. 2005. PMID: 16248277 Review.

9

Gene therapy for glioblastoma.

Aghi M, Chiocca EA. Aghi M, et al. Neurosurg Focus. 2006 Apr 15;20(4):E18. Neurosurg Focus. 2006. PMID: 16709023 Review.

10

Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes.

Aghi M, Cohen KS, Klein RJ, Scadden DT, Chiocca EA. Aghi M, et al. Cancer Res. 2006 Sep 15;66(18):9054-64. doi: 10.1158/0008-5472.CAN-05-3759. Cancer Res. 2006. PMID: 16982747

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters